CHARLESTON, S.C., Sept. 1, 2010 (GLOBE NEWSWIRE) -- Revolutions Medical ("Revolutions Medical" or the "Company") (OTCBB:RMCP) is entering the final stage of the process to determine its initial global distributors. Since receiving FDA clearance for its RevVac safety syringe, the Company has received numerous inquiries to distribute its product. The potential future distributors have been narrowed down to a pool of just under 50 distributors. Over the next several weeks, the Company will be sending out market samples, confirming interest and commitments, and signing distribution agreements covering certain countries and regions, as well as global licensing agreements.
Tom O'Brien, President of Revolutions Medical stated, "The market demand for our RevVac Safety Syringe and the significant interest from global distributors is comparable to other revolutionary product releases that I have experienced over the course of my long career. The fact that we should be able to save lives and bring down the cost of health care by the implementation of our Safety Syringe, makes me very proud to be an integral part of our product roll out."
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its products include the RevVac safety syringe (FDA approved), safety blood drawing device and safety IV catheter. The Company also provides RevColor, RevDisplay and Rev3D -- software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software suite's functionality includes sorting of images, color, 3D and automatic segmentation of images.
For additional information, please visit Revolutions Medical corporate website:
Investor Resource Center
RevVac Safety Syringe Demonstration Video:
RevColor MRI Video:
To be added to the Company's investor email list, please email with RMCP in the subject line.
Become a RevMed fan and follow the Company on Facebook – visit http://www.Facebook.com/Revmed
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.
CONTACT: Revolutions Medical Corporation Investor Relations: Scott Key (843) 518-0437 Skey@revolutionsmedical.com